Add to Calendar 1/16/2019 4:00:00 PM 1/16/2019 6:00:00 PM 2019 JP Morgan Recap: Insider's View The annual JP Morgan Healthcare Conference in San Francisco is one of the largest and most informative healthcare investment symposiums in the industry. It brings together global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Each year hundreds of companies, both public and private, deliver presentations to over 4,000 investors. In addition, thousands in biotech descend upon San Francisco to network, attend meetings and gain an inside view even if they can’t secure an official conference invite. With the Trump administration geared up to make some changes, what can we expect in 2019 in regard to drug pricing, the regulatory environment and capital markets. If you can’t make it to the conference, or if your role does not require you to attend the JP Morgan conference, join us for a recap of it and hear from a select group of Conference insiders. MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
Chief Business Officer
Melissa Bradford Klug is chief business officer at Keryx and is responsible for business development, corporate strategy and alliance management. She joined Keryx in January 2017 bringing to the company more than 17 years of strategic planning, licensing and business development expertise in the life sciences industry. Prior to Keryx, Ms. Bradford Klug was at AMAG Pharmaceuticals, from 2014 to 2016, where she served as senior vice president of business development and strategy and executed multiple transformational acquisitions that led to AMAG’s portfolio expansion into maternal and women’s health. Prior to AMAG, she spent approximately 10 years at Mallinckrodt where she was vice president, business development and licensing. During her tenure at Mallinckrodt, she completed several transformational acquisitions and divestitures and was instrumental in the spinout of Mallinckrodt from Covidien. Earlier in her career, she held leadership roles with Baxter International and Eli Lilly and Company. Ms. Bradford Klug received an M.B.A. in Finance from DePaul University and a B.S. in chemistry from Maryville University. Melissa currently serves on the MassBio Board of Directors.